Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceutical Inc.
WKN: 766093 / Symbol: RIGL / Name: Rigel Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,74 €
-0,51 %
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $49.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $42.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (RIGL) had its "buy" rating reaffirmed by HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (RIGL) had its "buy" rating reaffirmed by HC Wainwright. They now have a $57.00 price target on the stock.
Ratings data for RIGL provided by MarketBeat
Rigel Pharmaceuticals (RIGL) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for RIGL provided by MarketBeat
Neueste Beiträge
StockNews_com in Mercer International Inc. diskutieren